Verywell Health on MSN2mon
Spravato Nasal Spray Can Now Be Used Alone for Treatment-Resistant Depression
According to the prescribing information, patients treated with Spravato should receive a dose twice a week for the first ...
pharmaphorum2mon
J&J's Spravato gets another lift with new FDA approval
In some patients, there was a measurable shift on the MADRS scale within around 24 hours of the first dose, according to J&J. That speed of onset has been held up as the main benefit for Spravato ...
Psychology Today1y
Spravato | Tms Therapy | Sgb | Ketamine Infusions
Spravato (esketamine) nasal spray, transcranial magnetic stimulation (TMS), ketamine infusion therapy, stellate ganglion blocks (SGB) and integration therapy. Schedule an intake assessment to ...
Hosted on MSN2mon
FDA approves SPRAVATO as first monotherapy for MDD
MDD affects an estimated 21 million adults in the U.S., and about one-third of these patients do not respond to oral antidepressants alone. The approval of SPRAVATO® as a monotherapy provides a ...